How to differentiate induced pluripotent stem cells into sensory neurons for disease modelling: a functional assessment

Anil Kumar Kalia,Corinna Rösseler,Rafael Granja-Vazquez,Ayesha Ahmad,Joseph J. Pancrazio,Anika Neureiter,Mei Zhang,Daniel Sauter,Irina Vetter,Asa Andersson,Gregory Dussor,Theodore J. Price,Benedict J. Kolber,Vincent Truong,Patrick Walsh,Angelika Lampert

DOI: https://doi.org/10.1186/s13287-024-03696-2

2024-04-06

Stem Cell Research & Therapy

Abstract:Human induced pluripotent stem cell (iPSC)-derived peripheral sensory neurons present a valuable tool to model human diseases and are a source for applications in drug discovery and regenerative medicine. Clinically, peripheral sensory neuropathies can result in maladies ranging from a complete loss of pain to severe painful neuropathic disorders. Sensory neurons are located in the dorsal root ganglion and are comprised of functionally diverse neuronal types. Low efficiency, reproducibility concerns, variations arising due to genetic factors and time needed to generate functionally mature neuronal populations from iPSCs remain key challenges to study human nociception in vitro. Here, we report a detailed functional characterization of iPSC-derived sensory neurons with an accelerated differentiation protocol ("Anatomic" protocol) compared to the most commonly used small molecule approach ("Chambers" protocol). Anatomic's commercially available RealDRGTM were further characterized for both functional and expression phenotyping of key nociceptor markers.

cell biology,medicine, research & experimental,cell & tissue engineering

What problem does this paper attempt to address?

The paper aims to address the following issues:

1. **Comparison of Two Differentiation Protocols**: The paper compares two methods for differentiating induced pluripotent stem cells (iPSCs) into sensory neurons. One is the commonly used "Chambers" protocol, and the other is an accelerated differentiation protocol from Anatomic Company (referred to as the "Anatomic protocol"). The study aims to evaluate the efficiency and effectiveness of these two methods in generating functionally mature sensory neurons.

2. **Disease Modeling Tool**: Using iPSC-derived sensory neurons to establish disease models, particularly for pain disorders. Specifically, the paper utilizes iPSCs from patients with hereditary pain syndromes (such as inherited erythromelalgia [IEM] and small fiber neuropathy [SFN]) to explore how these cells can be used to simulate disease phenotypes and serve as model systems for drug screening and the development of new treatments.

3. **Improving Differentiation Efficiency and Purity**: The Anatomic protocol can achieve purer neuronal cultures without the use of mitomycin C and shows different electrophysiological properties compared to the Chambers protocol. This suggests that the Anatomic protocol may be more suitable for high-throughput applications.

4. **Validation of Functional Assessment**: The paper validates the functional assessment capabilities of the two differentiation protocols and their potential in understanding the mechanisms of patient pain disorders. By comparing iPSCs from different sources (including healthy controls and disease patients), the paper demonstrates the excitability differences of these sensory neurons at the cellular level, thereby supporting their value as disease models.

Overall, this paper is dedicated to optimizing the process of differentiating iPSCs into sensory neurons and exploring the potential applications of these neurons in pain-related disease research.